• Participants
• Press
• News
• Workshops
• PhD studentship
• Training
• Job opportunities
• Network
• NeutNet
• Newsletter service
• Links

Adjuvants and Innate Immunity - 2-3 July 2009 (Brussels)

DOCUMENTS:

	DOCUMENT
	Agenda
	Participants
	Adjuvant Report (2010)

PRESENTATIONS:

2nd July

	DOCUMENT	AUTHOR
session 1 - Adjuvants – State of the Art and priority gaps
	New horizons in adjuvants for vaccine	Darrick Carter
	Polycation/anion adjuvants and routes of administration	Frank Wegmann
	Vaginal responses to candidate adjuvants	Ali Harandi
	Pertussis toxin and derivatives as adjuvants and antivirals	Guido Poli
	Aluminium based adjuvants	Erik B Lindblad
	IC31, a two component TLR-dependent adjuvant	Eszter Nagy
	Adjuvant development perspective of industry	Ennio De Gregorio
	Development of the ASO Adjuvant series	Robbert van der Most
	Regulatory issues related to use of vaccine adjuvants	Dorothea Sesardic

3rd July

	DOCUMENT	AUTHOR
session 2 - Innate immunity and biomarker analysis - current understanding and priority gaps
	Novel innate immune functions of the whey acidic protein family	Anna Vyakarnam
	Semen-derived amyloid fibrils and HIV infection	Frank Kirchhoff
	Impact of TLR7/8 triggering on HIV pathogenesis	Roberto F Speck
	Plasmacytoid and myeloid dendritic cells in HIV pathogenesis	Steve Patterson
	Species Specificity of Restriction by TRIM5/TRIMCyp and Tetherin	Greg Towers
	Antiviral APOBEC3G and putative memory in vivo in human HIV-1 and macaque SIV infections	Tom Lehner
	Innate immunity in natural SIV infections	Guido Silvestri